DNA SCHEDULE 13G/A: SEC filing
Cascade Investment, L.L.C. and William H. Gates III
Filed with the SEC on · accession 0001104659-26-128348
DNA filed a SCHEDULE 13G/A (schedule 13g/a) with the SEC on Nov 16, 2026. Cascade Investment, L.L.C. and William H. The stock moved -11.6% by the first close after the filing.
Summary of the filing
Cascade Investment, L.L.C. and William H. Gates III filed an amended Schedule 13G reporting beneficial ownership of 3,322,584 shares of Ginkgo Bioworks Class A common stock, representing approximately 6.2% of the outstanding shares as of September 30, 2026.
Key details
How DNA stock reacted
Close before
$9.61
Nov 13, 2026
First close after
-11.55%
$8.50
5 trading days
—
Since filing
—
✦ Ask GOAX AI about this filing — what it means for DNA, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for DNA?
Click hereFrequently asked questions
What did DNA file with the SEC on Nov 16, 2026?
DNA filed a SCHEDULE 13G/A (SEC filing). Cascade Investment, L.L.C. and William H. Gates III filed an amended Schedule 13G reporting beneficial ownership of 3,322,584 shares of Ginkgo Bioworks Class A common stock, representing approximately 6.2% of the outstanding shares as of September 30, 2026.
How do I read a SCHEDULE 13G/A?
A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G/A (schedule 13g/a): A report the company filed with the SEC (the US market regulator).
How did DNA stock react to this filing?
DNA closed at $9.61 before the filing and $8.50 on Nov 16, 2026 (-11.55%).
Other DNA SEC filings
- SCHEDULE 13G/A · SEC filingNov 16, 2026
- 10-Q · SEC filingNov 9, 2026
- 8-K · SEC filingNov 5, 2026
- 8-K · SEC filingOct 29, 2026
- 10-Q · SEC filingAug 6, 2026
- 8-K · SEC filingAug 5, 2026
- 8-K · SEC filingJul 30, 2026
- 8-K · Board changeJun 12, 2026
- 144 · Insider sale plannedJun 10, 2026
- 144 · Insider sale plannedMay 22, 2026
Get alerts when DNA files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days